“…In this direction, Kumar et al reported azo-Schiff base ligands like 2-(( E )-((4-(diethylamino)phenyl)imino)methyl)-4-(( E )-((2-phenylamino)phenyl)diazinyl)phenol containing Zn( ii ) complexes, which have been analyzed for their effective cytotoxicity properties against the Hut-78 cell line. 3 Hosseini et al also reported a doxorubicin-based bentonite nanoclay complex and used it to treat melanoma cells, which showed effective targeted drug delivery properties. 4 Generally, nanoparticulate clay, which we used in anti-cancer treatment, has drawn great attention as a drug carrier due to their better bio-compatibility, high specific surface area and high adsorption behavior.…”